Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Hematology Malignancy Innovations in Clinical Trials

UH Seidman Cancer Center - Innovations in Clinical Trials - publication cover

Current Issue:

May 2017


Past Issues:

October 2016


August 2015

  • JAN1A14: VMP +/- Daratumumab for untreated myeloma patients.
  • S1211: Elotuzumab and Bortezomib, Dexamethasone and Lenalidomide for newly diagnosed high-risk myeloma patients.
  • CASE4A13: Ixazomib (MLN9708) plus Panobinostat and Dexamethasone for relapsed myeloma
  • CASE1A09: Very low dose continuous azacytidine plus lenalidomide and dexamethasone for relapsed multiple myeloma.
  • E3A06: Lenalidomide for patients with high-risk smoldering myeloma
  • MLNM2A13: Ixazomib, lenalidomide and dexamethasone for newly diagnosed multiple myeloma
  • MLNM1A15: Ixazomib maintenance after induction therapy for patients ineligible for autologous transplantation

December 2014

  • MESO 1Z12: MSC Expanded Umbilical Cord Blood Transplant
  • CTN 1101: Umbilical Cord Blood vs. Haploidentical Transplants
  • BELL 1Z12: Haploidentical SCT with Genetically Modified T Cells to Stop GVHD
  • UNMC 1413: Lenalidomide Maintenance After Autologous SCT
  • CASE 9Z13: Targeted Marrow Irradiation in Reduced Intensity Stem Cell Transplant
  • CCASE 12Z13: Allogeneic Transplant for Patients with Sickle Cell Anemia
  • CASE 5913: Curcumin and Vitamin D for Patients with Early-Stage CLL Or SLL
  • PRE 1413: Rituximab vs. Obinotuzumab for Patients with Low-Burden, Advanced-Stage Follicular Lymphoma

April 2014

  • Treatment of High Risk Smoldering Myeloma
  • BCL2 Inhibition for High Risk Relapsed CLL
  • Lenalidomide plus R-CHOP for DLBCL
  • Methoxyamine and Temozolomide in Patients with Advanced Solid Tumors
  • Vaccine Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
  • Treatment of Renal Tumors in Poor Surgical Candidates

December 2013

  • Brentuximab Plus Bendamustine For Hodgkin Lymphoma In First Relapse
  • Oral Azacytidine For Myeloid Malignancies
  • Ex Vivo Umbilical Cord Blood Expansion With Human Mesenchymal Stem Cells (MSCs)
  • Differentiation Therapy For Acute Myeloid Leukemia